ORIGINAL RESEARCH article
Front. Biomater. Sci.
Sec. Delivery Systems and Controlled Release
Volume 4 - 2025 | doi: 10.3389/fbiom.2025.1394166
A 3D printed, High Strength and Drug Eluting Composite for the Treatment for Periprosthetic Joint Infections
Provisionally accepted- 1Thomas Lord Department of Mechanical Engineering & Materials Science, Pratt School of Engineering, Duke University, Durham, North Carolina, United States
- 2Department of Orthopaedic Surgery, School of Medicine, Duke University, Durham, North Carolina, United States
- 3Duke University Medical Center, Duke University, Durham, North Carolina, United States
- 4Division of Infectious Diseases, Department of Medicine, School of Medicine, Duke University, Durham, North Carolina, United States
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Periprosthetic joint infections are relatively rare complications of total joint replacements. The standard of care for these infections involves the placement of a temporary spacer made of poly(methyl methacrylate) (PMMA) bone cement combined with antibiotics. The rate of major complication can be as high as 12 % for PMMA spacers. Therefore, this study was designed to identify an alternative resin material that could be 3D printed, provide mechanical support necessary for ambulation, and deliver a therapeutic dose of antibiotics over an extended period. Test substrates were photochemically printed out of Biomed Clear (BMC) loaded with up to 16% gentamicin or 10 % vancomycin (wt%). PMMA and BMC composites were characterized using differential scanning calorimetry, dynamic mechanical analysis, compression testing, and a 30-day antibiotic elution study. The thermoset properties of the BMC allowed for the compressive properties to remain unchanged (post-elution = compressive strength 84 -94 MPa) as antibiotics were added to the resin (0 to 16 wt%). However, antibiotic elusion was influenced by the type and concentration of the antibiotic in the composite. In contrast, the thermoplastic properties of PMMA led to decrease compressive properties with the addition of antibiotics, but PMMA was able to elute relatively more antibiotics. This study described a novel method to 3D print load bearing materials that can release antibiotics over 30 days. BMC composites have some advantages and disadvantages compared to PMMA that need to be considered when developing new treatments for orthopaedic infections.
Keywords: PMMA, 3D printing, Patient specific implants, Drug elution, mechanical testing, Periprosthetic joint infections, antibiotics, orthopeadic
Received: 01 Mar 2024; Accepted: 26 May 2025.
Copyright: © 2025 Abar, Goonewardene, Sheng, Negus, Allen, Kelly, Stinson, Becker, Thaden, Adams and Gall. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Bijan Abar, Thomas Lord Department of Mechanical Engineering & Materials Science, Pratt School of Engineering, Duke University, Durham, NC 27708-0300, North Carolina, United States
Ken Gall, Thomas Lord Department of Mechanical Engineering & Materials Science, Pratt School of Engineering, Duke University, Durham, NC 27708-0300, North Carolina, United States
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.